LINC00920 and colorectal carcinoma: To elucidate the degradation pattern of IGF2BP, the CRC cells with downregulated LINRIS expression were treated with the protein synthesis inhibitor cycloheximide (CHX) and exhibited a shorter IGF2BP2 half-life than the untreated control cells (Fig. 3e).